Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Retained Earnings (2017 - 2021)

Cogent Biosciences (COGT) has 4 years of Retained Earnings data on record, last reported at -$246.1 million in Q3 2021.

  • For Q3 2021, Retained Earnings fell 31.35% year-over-year to -$246.1 million; the TTM value through Sep 2021 reached -$246.1 million, down 31.35%, while the annual FY2020 figure was -$198.7 million, 60.38% down from the prior year.
  • Retained Earnings reached -$246.1 million in Q3 2021 per COGT's latest filing, down from -$227.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$2000.0 in Q1 2019 and bottomed at -$246.1 million in Q3 2021.
  • Average Retained Earnings over 4 years is -$125.1 million, with a median of -$126.2 million recorded in 2019.
  • Peak YoY movement for Retained Earnings: soared 71.43% in 2019, then tumbled 6499200.0% in 2020.
  • A 4-year view of Retained Earnings shows it stood at -$92.1 million in 2018, then tumbled by 34.58% to -$123.9 million in 2019, then plummeted by 60.38% to -$198.7 million in 2020, then fell by 23.86% to -$246.1 million in 2021.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$246.1 million in Q3 2021, -$227.0 million in Q2 2021, and -$210.4 million in Q1 2021.